Determining the correct stoichiometry of Kv2.1/Kv6.4 heterotetramers, functional in multiple stoichiometrical configurations.


Journal

Proceedings of the National Academy of Sciences of the United States of America
ISSN: 1091-6490
Titre abrégé: Proc Natl Acad Sci U S A
Pays: United States
ID NLM: 7505876

Informations de publication

Date de publication:
28 04 2020
Historique:
pubmed: 15 4 2020
medline: 11 8 2020
entrez: 15 4 2020
Statut: ppublish

Résumé

The electrically silent (KvS) members of the voltage-gated potassium (Kv) subfamilies Kv5, Kv6, Kv8, and Kv9 selectively modulate Kv2 subunits by forming heterotetrameric Kv2/KvS channels. Based on the reported 3:1 stoichiometry of Kv2.1/Kv9.3 channels, we tested the hypothesis that Kv2.1/Kv6.4 channels express, in contrast to the assumed 3:1, in a 2:2 stoichiometry. We investigate the Kv2.1/Kv6.4 stoichiometry using single subunit counting and functional characterization of tetrameric concatemers. For selecting the most probable stoichiometry, we introduce a model-selection method that is applicable for any multimeric complex by investigating the stoichiometry of Kv2.1/Kv6.4 channels. Weighted likelihood calculations bring rigor to a powerful technique. Using the weighted-likelihood model-selection method and analysis of electrophysiological data, we show that Kv2.1/Kv6.4 channels express, in contrast to the assumed 3:1, in a 2:2 stoichiometry. Within this stoichiometry, the Kv6.4 subunits have to be positioned alternating with Kv2.1 to express functional channels. The variability in Kv2/KvS assembly increases the diversity of heterotetrameric configurations and extends the regulatory possibilities of KvS by allowing the presence of more than one silent subunit.

Identifiants

pubmed: 32284408
pii: 1916166117
doi: 10.1073/pnas.1916166117
pmc: PMC7196910
doi:

Substances chimiques

Antibodies 0
KCNB1 protein, human 0
KCNG4 protein, human 0
Kcnb1 protein, mouse 0
Potassium Channels, Voltage-Gated 0
Recombinant Proteins 0
Shab Potassium Channels 0
Ltk protein, mouse EC 2.7.10.1
Receptor Protein-Tyrosine Kinases EC 2.7.10.1
Potassium RWP5GA015D

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

9365-9376

Subventions

Organisme : CIHR
ID : MOP-136894
Pays : Canada

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Déclaration de conflit d'intérêts

The authors declare no competing interest.

Références

J Neurosci. 1997 Jan 1;17(1):32-44
pubmed: 8987734
Proc Natl Acad Sci U S A. 2013 May 21;110(21):8732-7
pubmed: 23650380
Ann Neurol. 2019 Dec;86(6):899-912
pubmed: 31600826
Biophys J. 2015 Aug 18;109(4):710-21
pubmed: 26287623
Proc Natl Acad Sci U S A. 2009 Jul 14;106(28):11558-63
pubmed: 19556541
Biophys J. 1994 Mar;66(3 Pt 1):667-73
pubmed: 8011897
J Physiol. 2012 Apr 1;590(7):1599-614
pubmed: 22289912
J Gen Physiol. 2010 Sep;136(3):273-82
pubmed: 20805574
Physiology (Bethesda). 2012 Apr;27(2):73-84
pubmed: 22505664
Neuron. 1992 Nov;9(5):861-71
pubmed: 1419000
Neuron. 1992 Mar;8(3):493-7
pubmed: 1550674
Nat Methods. 2014 Feb;11(2):156-62
pubmed: 24390439
Science. 1992 Aug 28;257(5074):1225-30
pubmed: 1519059
Sci Rep. 2015 Aug 05;5:12813
pubmed: 26242757
Biochem J. 2013 Aug 15;454(1):101-8
pubmed: 23725331
PLoS One. 2012;7(5):e37143
pubmed: 22615922
Biophys J. 1992 Nov;63(5):1406-11
pubmed: 1477286
J Biol Chem. 2015 Sep 11;290(37):22724-33
pubmed: 26209633
J Biol Chem. 2010 Apr 30;285(18):14005-19
pubmed: 20202932
FEBS Lett. 1996 Dec 9;399(1-2):177-82
pubmed: 8980147
J Biol Chem. 2009 Nov 13;284(46):31625-34
pubmed: 19717558
PLoS One. 2014 Jun 05;9(6):e98960
pubmed: 24901643
Mol Biol Cell. 2016 Aug 15;27(16):2542-53
pubmed: 27335124
Proc Natl Acad Sci U S A. 1998 Nov 24;95(24):14546-51
pubmed: 9826737
Proc Natl Acad Sci U S A. 2002 Jun 11;99(12):7986-91
pubmed: 12060745
Sci Rep. 2018 Jul 13;8(1):10634
pubmed: 30006597
J Biol Chem. 2014 Jun 20;289(25):17597-609
pubmed: 24811166
Nat Methods. 2007 Apr;4(4):319-21
pubmed: 17369835
J Gen Physiol. 1984 Oct;84(4):535-64
pubmed: 6094704
J Neurosci. 2012 Sep 12;32(37):12915-20
pubmed: 22973015
Biophys J. 1999 Apr;76(4):2004-17
pubmed: 10096897
Neuron. 1993 Jul;11(1):67-76
pubmed: 8338669
Science. 1990 Oct 12;250(4978):276-9
pubmed: 2218530
PLoS One. 2015 Oct 27;10(10):e0141349
pubmed: 26505474
Biochemistry. 2001 Sep 18;40(37):10934-46
pubmed: 11551188
J Biol Chem. 2012 Oct 19;287(43):35912-21
pubmed: 22930752
Neuron. 1995 Mar;14(3):625-33
pubmed: 7695909
Psychon Bull Rev. 2004 Feb;11(1):192-6
pubmed: 15117008
Neuron. 1992 Mar;8(3):483-91
pubmed: 1550673
Proc Natl Acad Sci U S A. 2013 Mar 26;110(13):5034-9
pubmed: 23479619
J Gen Physiol. 2018 Dec 3;150(12):1702-1721
pubmed: 30322883
J Biol Chem. 1996 Aug 2;271(31):18904-11
pubmed: 8702552
Proc Natl Acad Sci U S A. 2005 Apr 26;102(17):6160-5
pubmed: 15827117
J Physiol. 2005 Nov 1;568(Pt 3):737-47
pubmed: 16096342
Biophys J. 2006 Nov 15;91(10):3673-83
pubmed: 16920836
Biochim Biophys Acta. 2016 Jan;1863(1):19-29
pubmed: 26453803
Proc Natl Acad Sci U S A. 2010 Nov 2;107(44):18862-7
pubmed: 20962273
J Biol Chem. 2009 Feb 13;284(7):4695-704
pubmed: 19074135
J Gen Physiol. 2016 Feb;147(2):105-25
pubmed: 26755771
Biophys J. 2003 Dec;85(6):3587-99
pubmed: 14645052
J Neurochem. 1999 Apr;72(4):1725-34
pubmed: 10098883
J Biol Chem. 2012 Apr 6;287(15):11870-7
pubmed: 22334706
Pharmacol Rev. 2005 Dec;57(4):473-508
pubmed: 16382104
J Biol Chem. 1995 Oct 20;270(42):24761-8
pubmed: 7559593
Sci Rep. 2015 Sep 11;5:14072
pubmed: 26358640
Biophys J. 2015 Dec 1;109(11):2352-62
pubmed: 26636946

Auteurs

Lena Möller (L)

Department of Biochemistry, Université de Montréal, Montréal, QC, Canada H3C 3J7.

Glenn Regnier (G)

Laboratory for Molecular, Cellular and Network Excitability, Department of Biomedical Sciences, University of Antwerp, 2000 Antwerp, Belgium.

Alain J Labro (AJ)

Laboratory for Molecular, Cellular and Network Excitability, Department of Biomedical Sciences, University of Antwerp, 2000 Antwerp, Belgium.

Rikard Blunck (R)

Department of Biochemistry, Université de Montréal, Montréal, QC, Canada H3C 3J7; rikard.blunck@umontreal.ca dirk.snyders@ua.ac.be.
Department of Physics, Université de Montréal, Montréal, QC, Canada H3C 3J7.

Dirk J Snyders (DJ)

Laboratory for Molecular, Cellular and Network Excitability, Department of Biomedical Sciences, University of Antwerp, 2000 Antwerp, Belgium; rikard.blunck@umontreal.ca dirk.snyders@ua.ac.be.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH